Interventions to improve locomotive syndrome: a systematic review and meta-analysis of randomized controlled trials

1 Nakamura K. Locomotive syndrome: disability-free life expectancy and locomotive organ health in a

“super-aged” society. J Orthop Sci. 2009;14(1):1–2. doi:10.1007/s00776-008-1302-y.

2 Matsumoto H, Hagino H, Wada T, Kobayashi E. Locomotive syndrome presents a risk for falls and

fractures in the elderly Japanese population. Osteoporos Sarcopenia. 2016;2(3):156–163. doi:10.1016/j.

afos.2016.06.001.

3 Chua KY, Lin X, Wang Y, Chong YS, Lim WS, Koh WP. Visceral fat area is the measure of obesity

best associated with mobility disability in community dwelling oldest-old Chinese adults. BMC Geriatr.

2021;21(1):282. doi:10.1186/s12877-021-02226-6.

4 Anees N, Saeed A, Riaz H, Khan FM. Association of locomotive syndrome risk with knee osteoarthritis.

RMJ. 2020;45(4):846–849.

5 Mahali NS, Hosseini MA, Tabrizi KN, Rahgozar M, Kavari SH. The relationship between locomotive

syndrome and quality of life in the elderly. J Evol Med Dent Sci. 2018;7(34):3791–3795. doi:10.14260/

jemds/2018/850.

6 Nagilla J, Nagarajan S, Trovagunta LG, Gakkula H, Anuup KP, Rampalli VC. Teeth loss and its association with locomotive syndrome among patients visiting the outpatient department of a dental school

in M

­ ahbubnagar, India-A cross sectional study. Acta Biomed. 2021;92(2):e2021040. doi:10.23750/abm.

v92i2.9130.

7 Pazan F, Petrovic M, Cherubini A, et al. Current evidence on the impact of medication optimization or

Nagoya J. Med. Sci. 85. 275–288, 2023

285

doi:10.18999/nagjms.85.2.275

Yoshitaka Iwamoto et al

8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled

trials. Eur J Clin Pharmacol. 2021;77(1):1–12. doi:10.1007/s00228-020-02951-8.

Han CY, Miller M, Yaxley A, Baldwin C, Woodman R, Sharma Y. Effectiveness of combined exercise and

nutrition interventions in prefrail or frail older hospitalised patients: a systematic review and meta-analysis.

BMJ Open. 2020;10(12):e040146. doi:10.1136/bmjopen-2020-040146.

Talar K, Hernández-Belmonte A, Vetrovsky T, Steffl M, Kałamacka E, Courel-Ibáñez J. Benefits of Resistance Training in Early and Late Stages of Frailty and Sarcopenia: A Systematic Review and Meta-Analysis

of Randomized Controlled Studies. J Clin Med. 2021;10(8):1630. doi:10.3390/jcm10081630.

Wu PY, Huang KS, Chen KM, Chou CP, Tu YK. Exercise, Nutrition, and Combined Exercise and

Nutrition in Older Adults with Sarcopenia: A Systematic Review and Network Meta-analysis. Maturitas.

2021;145:38–48. doi:10.1016/j.maturitas.2020.12.009.

Ruiz JG, Dent E, Morley JE, et al. Screening for and Managing the Person with Frailty in Primary Care:

ICFSR Consensus Guidelines. J Nutr Health Aging. 2020;24(9):920–927. doi:10.1007/s12603-020-1492-3.

Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis.

Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169.

Ishibashi H. Locomotive syndrome in Japan. Osteoporos Sarcopenia. 2018;4(3):86–94. doi:10.1016/j.

afos.2018.09.004.

Aoki K, Sakuma M, Endo N. The impact of exercise and vitamin D supplementation on physical function in community-dwelling elderly individuals: A randomized trial. J Orthop Sci. 2018;23(4):682–687.

doi:10.1016/j.jos.2018.03.011.

Japanese Orthopaedic Association, Japanese Society for Muscyloskeletal Medicine. Locomotive Syndrome

[in Japanese]. Tokyo: Bunkodo; 2021.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and

meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med.

2009;6(7):e1000100. doi:10.1371/journal.pmed.1000100.

Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias

in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.

Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and

summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394. doi:10.1016/j.jclinepi.2010.04.026.

Yamakawa K, Aihara M, Ogura H, Yuhara H, Hamasaki T, Shimazu T. Recombinant human soluble thrombomodulin in severe sepsis: A systematic review and meta-analysis. J Thromb Haemost. 2015;13(4):508–519.

doi:10.1111/jth.12841.

Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions

version 6.3 (updated February 2022). Cochrane, 2022. https://www.training.cochrane.org/handbook. Accessed

February 7, 2022.

Nishikawa Y, Watanabe K, Kawade S, et al. The effect of a portable electrical muscle stimulation device

at home on muscle strength and activation patterns in locomotive syndrome patients: A randomized control

trial. J Electromyogr Kinesiol. 2019;45:46–52. doi:10.1016/j.jelekin.2019.02.007.

Shimoura K, Iijima H, Suzuki Y, Aoyama T. Immediate Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Physical Performance in Individuals With Preradiographic Knee Osteoarthritis: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2019;100(2):300–306.e1. doi:10.1016/j.apmr.2018.08.189.

Tomonaga A, Fukagawa M, Mitsui Y, Sato M, Fujita S, Nagaoka I. Effect of a dietary supplement containing

yeast SM-10 on joint functions of elderly individuals with knee joint pain: A randomized double-blind

placebo-controlled clinical study [in Japanese]. Jpn Pharmacol Ther. 2017;45(6):1031–1044.

Yamamoto T, Mori S, Fukagawa M, Tomonaga A, Morita M, Nagaoka I. Effects of oral intake of collagen

peptides on Knee Joint Pain and discomfort – A randomized, double-blind, placebo-controlled parallel-group,

comparison study [in Japanese]. Jpn Pharmacol Ther. 2018;46(5):837–847.

Nagaoka I, Tomonaga A, Fukagawa M, Mitsui Y, Sato M, Fujita S. Effect of a dietary supplement containing

yeast SM-10 on joint functions of elderly individuals with knee joint pain [in Japanese]. Funct Food Res.

2018;14:48–56. doi: 10.32153/ffr.14.0_48

Hattori T, Murata R, Fukagawa M, Tomonaga A, Nagaoka I. The effect of the dietary supplement containing

both glucosamine and chondroitin sulfate on gait of healthy volunteer – A randomized, placebo-controlled,

double-blind, clinical study – [in Japanese]. Jpn Pharmacol Ther. 2016;44(5):725–735.

Najima M, Shirakawa T, Ishii I, Okamoto K. A study for evaluating the effect of the supplement containing glucosamine on joint performance and daily physical performance: A randomized, double-blind,

placebo-controlled, study mainly evaluated by subjects-oriented questionnaire. Jpn Pharmacol Ther.

2017;45(6):939–955.

Nagoya J. Med. Sci. 85. 275–288, 2023

286

doi:10.18999/nagjms.85.2.275

Interventions to improve LS

28 Hattori T, Arimura H, Murata R, Fukagawa M, Tomonaga A, Nagaoka I. The effect of the dietary supplement containing both glucosamine and chondroitin sulfate on gait of healthy volunteer : A randomized,

placebo-controlled, double-blind, clinical study-stratified analysis based on JKOM and body Weight [in

Japanese]. Jpn Pharmacol Ther. 2019;47(6):957–964.

29 Inada Y, Tohda C, Yang X. Effects of Cistanche tubulosa Wight Extract on Locomotive Syndrome: A

Placebo-Controlled, Randomized, Double-Blind Study. Nutrients. 2021;13(1):264. doi:10.3390/nu13010264.

30 Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses:

a large survey. CMAJ. 2007;176(8):1091–1096. doi:10.1503/cmaj.060410.

31 Momomura R, Naito K, Igarashi M, et al. Evaluation of the effect of glucosamine administration on biomarkers of cartilage and bone metabolism in bicycle racers. Mol Med Rep. 2013;7(3):742–746. doi:10.3892/

mmr.2013.1289.

32 Nakamura H, Shibakawa A, Tanaka M, Kato T, Nishioka K. Effects of glucosamine hydrochloride on the

production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in

osteoarthritis. Clin Exp Rheumatol. 2004;22(3):293–299.

33 Hua J, Sakamoto K, Nagaoka I. Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis,

on the functions of neutrophils. J Leukoc Biol. 2002;71(4):632–640.

34 Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis

Cartilage. 1998;6 Suppl A:14–21. doi:10.1016/s1063-4584(98)80006-x.

35 Broekmans T, Roelants M, Feys P, et al. Effects of long-term resistance training and simultaneous electrostimulation on muscle strength and functional mobility in multiple sclerosis. Mult Scler. 2011;17(4):468–477.

doi:10.1177/1352458510391339.

36 Hasegawa S, Kobayashi M, Arai R, Tamaki A, Nakamura T, Moritani T. Effect of early implementation

of electrical muscle stimulation to prevent muscle atrophy and weakness in patients after anterior cruciate

ligament reconstruction. J Electromyogr Kinesiol. 2011;21(4):622–630. doi:10.1016/j.jelekin.2011.01.005.

37 Dunlop DD, Hughes SL, Manheim LM. Disability in activities of daily living: patterns of change and a

hierarchy of disability. Am J Public Health. 1997;87(3):378–383. doi:10.2105/ajph.87.3.378.

Nagoya J. Med. Sci. 85. 275–288, 2023

287

doi:10.18999/nagjms.85.2.275

Yoshitaka Iwamoto et al

Appendix 1

Search strategy

【Medline】

#1 locomotive syndrome[Title/Abstract]

#2 (((((randomized[Title/Abstract]) OR (placebo[Title/Abstract])) OR (drug therapy[Title/

Abstract])) OR (randomly[Title/Abstract])) OR (trial[Title/Abstract])) OR (groups[Title/Abstract])

#3 #1 AND #2

【Cochrane Central Register of Controlled Trial】

#1 (locomotive syndrome):ti,ab,kw

#2 (randomized):ti,ab,kw OR (placebo):ti,ab,kw OR (drug therapy):ti,ab,kw OR (randomly):ti,ab,kw

OR (trial):ti,ab,kw OR (groups):ti,ab,kw

#3 #1 AND #2

【Physiotherapy Evidence Database (PEDro)】

“locomotive syndrome”

【Scopus】

TITLE-ABS-KEY ( “locomotive syndrome” ) AND ( TITLE-ABS-KEY ( randomized ) OR

TITLE-ABS-KEY ( placebo ) OR TITLE-ABS-KEY ( “drug therapy” ) OR TITLE-ABS-KEY

( randomly ) OR TITLE-ABS-KEY ( trial ) OR TITLE-ABS-KEY ( groups ) )

【Web of Science】

#1 ALL=(“locomotive syndrome”)

#2 (((((ALL=(randomized)) OR ALL=(placebo)) OR ALL=(“drug therapy”)) OR ALL=(randomly))

OR ALL=(trial)) OR ALL=(groups)

#3 (#1) AND (#2)

【Ichushi Web [in Japanese]】

(ロコモティブシンドローム/TH or ロコモティブシンドローム/AL) and (RD=ランダム化比

較試験)

【Cumulative Index to Nursing and Allied Health Literature】

“locomotive syndrome” AND (randomized OR placebo OR “drug therapy” OR randomly OR

trial OR groups)

References End

Nagoya J. Med. Sci. 85. 275–288, 2023

288

doi:10.18999/nagjms.85.2.275

...